Wegovy is a brand-name injection prescribed for weight management and to lower risk of cardiovascular problems. Wegovy contains the active ingredient semaglutide and belongs to the GLP-1 drug class.

Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission from purchases made through links on this page. Patients who took an ...

Stopping Wegovy, especially suddenly, can lead to weight regain, potentially reversing progress made during treatment. Ending Wegovy treatment may also increase cardiovascular risks and raise blood ...